The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma

References

• O’NeillJHMurrayNMFNewsom-DavisJThe Lambert-Eaton myasthenic syndrome – a review of 50 casesBrain1988111Pt 35775962838124
   PubMed Web of Science ®Google Scholar
• AndersonHJChurchill-DavidsonHCRichardsonATBronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholineLancet195326567991291129313110148
   PubMed Web of Science ®Google Scholar
• HeathfieldKWWilliamsJRPeripheral neuropathy and myopathy associated with bronchogenic carcinomaBrain195477112213713160261
   PubMed Web of Science ®Google Scholar
• LambertEHEatonLMRookeEDDefect of neuromuscular conduction associated with malignant neoplasmsAm J Physiol19561873612613
   Google Scholar
• EatonLMLambertEHElectromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumorsJAMA19571631311171124
   Web of Science ®Google Scholar
• LambertEHElmqvistDQuantal components of end-plate potentials in myasthenic syndromeAnn NY Acad Sci1971183Nsep1831994330759
   PubMed Web of Science ®Google Scholar
• LangBNewsom-DavisJWrayDVincentAMurrayNAutoimmune aetiology for myasthenic (Eaton-Lambert) syndromeLancet1981282402242266114283
   PubMed Web of Science ®Google Scholar
• Newsom-DavisJMurrayNWrayDLambert-Eaton Myasthenic Syndrome – electro-physiological evidence for a humoral factorMuscle Nerve198259SS17S206302493
   PubMed Web of Science ®Google Scholar
• LindstromJMLambertEHContent of acetylcholine-receptor and antibodies bound to receptor in myasthenia-gravis, experimental auto-immune myasthenia-gravis, and Eaton-Lambert SyndromeNeurology1978282130138202890
   PubMed Web of Science ®Google Scholar
• FukunagaHEngelAGOsameMLambertEHPaucity and disorganization of pre-synaptic membrane active zones in the Lambert-Eaton myasthenic syndromeMuscle Nerve198259686697
   Web of Science ®Google Scholar
• FukunagaHEngelAGLangBNewsom-DavisJVincentAPassive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zonesProc Natl Acad Sci U S A19838024763676406584877
   PubMed Web of Science ®Google Scholar
• LangBNewsom-DavisJPriorCWrayDThe effect of passively transferred Lambert-Eaton myasthenic syndrome antibodies on the calcium sensitivity of transmitter release in the mouseJ Physiol1984357P28P28
   Web of Science ®Google Scholar
• RobertsAPereraSLangBVincentANewsom-DavisJPara-neoplastic myasthenic syndrome IgG inhibits Ca-45(2+) flux in a human small cell-carcinoma lineNature198531760397377392414666
   PubMed Web of Science ®Google Scholar
• LangBNewsom-DavisJPeersCPriorCWrayDWThe effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouseJ Physiol19873902572702450991
   PubMed Web of Science ®Google Scholar
• NagelAEngelAGLangBNewsom-DavisJFukuokaTLambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulationAnn Neurol19882445525582853605
   PubMed Web of Science ®Google Scholar
• LangBVincentAMurrayNMFNewsom-DavisJLambert-Eaton myasthenic syndrome – immunoglobulin-G inhibition of Ca-2+ flux in tumor-cells correlates with disease severityAnn Neurol19892532652712543262
   PubMed Web of Science ®Google Scholar
• NakaoYKMotomuraMFukudomeTSeronegative Lambert-Eaton myasthenic syndromeNeurology200259111773177512473768
   PubMed Web of Science ®Google Scholar
• TitulaerMJWirtzPWKuksJBMThe Lambert-Eaton myasthenic syndrome 1988–2008: A clinical picture in 97 patientsJ Neuroimmunol200820115315818644631
   PubMed Web of Science ®Google Scholar
• WirtzPWvan DijkJGvan DoornPAThe epidemiology of the Lambert-Eaton myasthenic syndrome in The NetherlandsNeurology200463239739815277653
   PubMed Web of Science ®Google Scholar
• TimRWMasseyJMSandersDBLambert-Eaton myasthenic syndrome: electrodiagnostic finding and response to treatmentNeurology200054112176217810851390
   PubMed Web of Science ®Google Scholar
• TitulaerMJVerschuurenJJLambert-Eaton myasthenic syndrome: tumor versus nontumor formsAnn N Y Acad Sci2008113212913418567862
   PubMed Web of Science ®Google Scholar
• MorimotoMOsakiTNagaraYKodateMMotomuraMMuraiHThymoma with Lambert-Eaton myasthenic syndromeAnn Thorac Surg20108962001200320494066
   PubMed Web of Science ®Google Scholar
• Fernandez-TorronRArcochaJLopez-PicazoJMIsolated dysphagia due to paraneoplastic myasthenic syndrome with anti-P/Q-type voltage-gated calcium-channel and anti-acetylcholine receptor antibodiesNeuromuscul Disord201121212612821115345
   PubMed Web of Science ®Google Scholar
• TitulaerMJMaddisonPSontJKClinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMSJ Clin Oncol201129790290821245427
   PubMed Web of Science ®Google Scholar
• WirtzPWSmallegangeTMWintzenARVerschuurenJJDifferences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published casesClin Neurol Neurosurg2002104435936312140105
   PubMed Web of Science ®Google Scholar
• WirtzPWWintzenARVerschuurenJJLambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancerMuscle Nerve200532222622915793845
   PubMed Web of Science ®Google Scholar
• WirtzPWWillcoxNvan der SlikARHLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndromeJ Neuroimmunol20051591–223023715652424
   PubMed Web of Science ®Google Scholar
• TitulaerMJLangBVerschuurenJJLambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategiesLancet Neurology201110121098110722094130
   PubMed Web of Science ®Google Scholar
• OdabasiZDemirciAKimDSPostexercise facilitation of reflexes is not common in Lambert-Eaton myasthenic syndromeNeurology20025971085108712370470
   PubMed Web of Science ®Google Scholar
• PellkoferHLArmbrusterLLinkeRSchummFVoltzRManaging non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patientsJ Neuroimmunol20092171–2909419833394
   PubMed Web of Science ®Google Scholar
• Medicine AQACAAoEPractice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statementMuscle Nerve20012491236123811494280
   PubMed Web of Science ®Google Scholar
• MaddisonPNewsom-DavisJMillsKRDecay of postexercise augmentation in the Lambert-Eaton myasthenic syndrome: effect of coolingNeurology1998504108310879566398
   PubMed Web of Science ®Google Scholar
• OhSJKurokawaKClaussenGCRyanHFElectrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndromeMuscle Nerve200532451552016003742
   PubMed Web of Science ®Google Scholar
• LennonVAKryzerTJGriesmannGECalcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromesN Engl J Med199533222146714747739683
   PubMed Web of Science ®Google Scholar
• PayneMBradburyPLangBProspective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancerJ Thorac Oncol201051343819934775
   PubMed Web of Science ®Google Scholar
• MaddisonPLangBParaneoplastic neurological autoimmunity and survival in small-cell lung cancerJ Neuroimmunol200820115916218667241
   PubMed Web of Science ®Google Scholar
• MccannFVPettengillOSColeJJRussellJAGSorensonGDCalcium spike electrogenesis and other electrical-activity in continuously cultured small cell-carcinoma of the lungScience19812124499115511576262914
   PubMed Web of Science ®Google Scholar
• TakamoriMIwasaKKomaiKAntibodies to synthetic peptides of the alpha 1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndromeNeurology1997485126112659153453
   PubMed Web of Science ®Google Scholar
• IwasaKTakamoriMKomaiKMoriYRecombinant calcium channel is recognized by Lambert-Eaton myasthenic syndrome antibodiesNeurology200054375775910680821
   PubMed Web of Science ®Google Scholar
• ParsonsKTKwokWWLinear B-cell epitopes in Lambert-Eaton myasthenic syndrome defined by cell-free synthetic peptide bindingJ Neuroimmunol20021261–219019512020970
   PubMed Web of Science ®Google Scholar
• MotomuraMLangBJohnstonIPalaceJVincentANewsom-DavisJIncidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndromeJ Neurol Sci1997147135429094058
   PubMed Web of Science ®Google Scholar
• el FarOMarquezeBLevequeCAntigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndromeJ Neurochem1995644169617027891097
   PubMed Web of Science ®Google Scholar
• MerineySDHulsizerSCLennonVAGrinnellADLambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinomaAnn Neurol19964057397498957015
   PubMed Web of Science ®Google Scholar
• Martin-MoutotNDe HaroLSeagarMDistinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndromeJ Neuroimmunol20081971475318474401
   PubMed Web of Science ®Google Scholar
• PintoAGillardSMossFHuman autoantibodies specific for the alpha(1A) calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neuronsProc Natl Acad Sci U S A19989514832883339653186
   PubMed Web of Science ®Google Scholar
• GrausFLangBPozo-RosichPSaizACasamitjanaRVincentAP/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancerNeurology200259576476612221175
   PubMed Web of Science ®Google Scholar
• KazarianMLaird-OffringaIASmall-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapyMol Cancer2011103321450098
   PubMed Web of Science ®Google Scholar
• SabaterLTitulaerMSaizAVerschuurenJGureAOGrausFSOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndromeNeurology2008701292492818032743
   PubMed Web of Science ®Google Scholar
• WirtzPWLangBGrausFP/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancerJ Neuroimmunol20051641–216116515904978
   PubMed Web of Science ®Google Scholar
• MaddisonPNewsom-DavisJMillsKRSouhamiRLFavourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinomaLancet1999353914711711810023900
   PubMed Web of Science ®Google Scholar
• PellkoferHLArmbrusterLKrumbholzMLambert-Eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channelJ Neuroimmunol20082041–213613918809213
   PubMed Web of Science ®Google Scholar
• MonstadSEDrivsholmLStorsteinAHu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancerJ Clin Oncol200422579580014990634
   PubMed Web of Science ®Google Scholar
• MolgoJLundhHThesleffSPotency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular-transmission and the effect of pH changesEur J Pharmacol198061125346101553
   PubMed Web of Science ®Google Scholar
• WuZZLiDPChenSRPanHLAminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunitJ Biol Chem200928452364533646119850918
   PubMed Web of Science ®Google Scholar
• LindquistSStangelMUpdate on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridineNeuropsych Dis Treat20117341349
   PubMed Web of Science ®Google Scholar
• MaddisonPLangBMillsKNewsom-DavisJLong term outcome in Lambert-Eaton myasthenic syndrome without lung cancerJ Neurol Neurosurg Psychiatry200170221221711160470
   PubMed Web of Science ®Google Scholar
• PatwaHSChaudhryVKatzbergHRae-GrantADSoYTEvidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyNeurology201278131009101522454268
   PubMed Web of Science ®Google Scholar
• BainPGMotomuraMNewsom-DavisJEffects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndromeNeurology19964736786838797464
   PubMed Web of Science ®Google Scholar
• MaddisonPMcConvilleJFarrugiaMEThe use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndromeJ Neurol Neurosurg Psychiatry201182667167320392977
   PubMed Web of Science ®Google Scholar